학술논문
Genetic determinants of response and survival in momelotinib-treated patients with myelofibrosis.
Document Type
Article
Author
Source
Subject
*MYELOFIBROSIS
*DRUG therapy
*PATIENTS
*
*
Language
ISSN
0887-6924
Abstract
A letter to the editor is presented in response to an article related to survival rate of patients suffering from myelofibrosis if treated with momelotinib drug, published in previous issue.